Ninlaro (ixazomib capsules – Takeda) — Cigna
Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma
Initial criteria
- Patient is age ≥ 18 years
- The medication is used in combination with a rituximab product and dexamethasone
Approval duration
1 year